ID
12725
Beschrijving
High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00136448
Link
https://clinicaltrials.gov/show/NCT00136448
Trefwoorden
Versies (1)
- 11-12-15 11-12-15 - Julian Varghese
Geüploaded op
11 december 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myelogenous Leukemia NCT00136448
Eligibility Acute Myelogenous Leukemia NCT00136448
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
History of an antecedent hematologic malignancy such as myelodysplastic syndromes (mds).
Datatype
boolean
Alias
- UMLS CUI [1]
- C0376545
Beschrijving
Uncontrolled infection
Datatype
boolean
Alias
- UMLS CUI [1]
- C0517627
Beschrijving
History of a previous or concomitant malignancy other than non-melanoma skin cancer.
Datatype
boolean
Alias
- UMLS CUI [1]
- C2735088
- UMLS CUI [2,1]
- C0009488
- UMLS CUI [2,2]
- C0006826
Beschrijving
Evidence of central nervous system (cns) leukemia.
Datatype
boolean
Alias
- UMLS CUI [1]
- C1332884
Beschrijving
Current use of corticosteroids.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0001617
Beschrijving
Prior treatment for aml, other than hydroxyurea.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0023467
Similar models
Eligibility Acute Myelogenous Leukemia NCT00136448
- StudyEvent: Eligibility
C0201899 (UMLS CUI [2])
C0201850 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C0009488 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0023467 (UMLS CUI [1,2])